How LPs Evaluate GP Continuation Fund Liquidity

In this episode, Lucas and Luna explore the growing role of continuation funds in private equity and venture capital as a liquidity tool for limited partners. Using the 2021 KKR-led continuation vehicle for Lyra Health as a case study, they break down how LPs should evaluate a GP's track record in these vehicles—looking at valuation discipline, alignment of interests, transparency, and the GP's historical use of such funds. They discuss why some LPs view continuation funds as a red flag while others see them as a strategic option, and they offer practical questions for limited partners to ask during due diligence. The conversation also touches on the secondary market's evolution and what the future holds for liquidity solutions in private markets. #ContinuationFunds #Liquidity #LP #LimitedPartners #VentureCapital #PrivateEquity #SecondaryMarket #LyraHealth #KKR #GPAlignment #Valuation #Transparency #VCInvesting #PrivateMarkets #Finance #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo